August 21st 2025
Patients with higher exposure to nature and green spaces were significantly less likely to experience dry eye, investigators reported
Is 'preconditioning' the cornea a new key to transplant success?
July 2nd 2010British and German scientists Dr Claus Cursiefen and his colleagues have reported that transplanted corneas are more likely to fail or be rejected in patients whose eyes exhibit abnormal vessel growth, called corneal neovascularization, before surgery.
Tear cytokine and chemokine analysis and clinical correlations in evaporative-type dry eye disease
June 17th 2010In a sample of moderate evaporative-type dry eye disease patients Enriquez-de-Salamanca et al., elevated five inflammatory molecules. Fracktalkine was demonstrated to be present and elevated in tears in human DED.
Producing corneas for human transplant
December 9th 2009Northeastern University engineering professor Jeffrey Ruberti and his research colleagues are breaking new ground in the technique known as "hybrid tissue engineering" by attempting to combine cow tissue with human tissue to produce corneas for human transplant.
Progress in corneal biomechanics
October 1st 2009Researchers are looking into corneal biomechanics as a means to screen patients for keratectasia. The authors review signal interpretation from a non-contact applanation tonometer as it relates to corneal biomechanical indices such as corneal hysteresis.
Intraductal meibomian gland probing reduces inflammation
September 1st 2009A new technique of intraductal meibomian gland probing using disposable cannulas of various lengths appears highly effective in providing quick and lasting relief from inflammatory sysmptoms of obstructive meibomian gland disease.
New options in treating lid wiper epitheliopathy
September 1st 2009An oil-in-water and a corticosteroid were both effective in eliminating the signs and symptoms of lid wiper epitheliopathy after a 1-month active treatment phase in a recent study. Improvement was effectively maintained with the emollient eye drops in all patients over a 12-month period.